Family Screening-Based GWAS Reveals Variant Involved in Asthma Treatment Response | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A variant in the glucocorticoid-induced transcript 1 gene GLCCI1 can influence individuals' response to glucocorticoid treatment for asthma, according to a study online this week in the New England Journal of Medicine.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.